CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Market dynamics

3.3.1.Drivers

3.3.1.1.Rise in prevalence of neurological disorders
3.3.1.2.Increase in investments in R&D for neurological disorders

3.3.2.Restraints

3.3.2.1.Adverse effects and risks associated with neurostimulation devices

3.3.3.Opportunities

3.3.3.1.Use of neurostimulators for new indications

CHAPTER 4:NEUROSTIMULATION DEVICES MARKET, BY DEVICE TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Spinal Cord Stimulators

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Deep Brain Stimulators

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

4.4.Sacral Nerve Stimulators

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

4.5.Vagus Nerve Stimulators

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country

4.6.Others

4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market analysis, by country

CHAPTER 5:NEUROSTIMULATION DEVICES MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Pain Management

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Hearing Loss

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.Urinary Incontinence

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

5.5.Parkinson's Disease

5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country

5.6.Epilepsy

5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country

5.7.Others

5.7.1.Market size and forecast, by region
5.7.2.Market analysis, by country

CHAPTER 6:GLOBAL NEUROSTIMULATION DEVICES MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast

6.2.North America

6.2.1.Key market trends and opportunities
6.2.2.Market size and forecast, by device type
6.2.3.Market size and forecast, by application
6.2.4.Market size and forecast, by country

6.2.4.1.U.S. market size and forecast, by device type
6.2.4.2.U.S. market size and forecast, by application
6.2.4.3.Canada market size and forecast, by device type
6.2.4.4.Canada market size and forecast, by application
6.2.4.5.Mexico market size and forecast, by device type
6.2.4.6.Mexico market size and forecast, by application

6.3.Europe

6.3.1.Key market trends and opportunities
6.3.2.Market size and forecast, by device type
6.3.3.Market size and forecast, by application
6.3.4.Market size and forecast, by country

6.3.4.1.Germany market size and forecast, by device type
6.3.4.2.Germany market size and forecast, by application
6.3.4.3.France market size and forecast, by device type
6.3.4.4.France market size and forecast, by application
6.3.4.5.UK market size and forecast, by device type
6.3.4.6.UK market size and forecast, by application
6.3.4.7.Italy market size and forecast, by device type
6.3.4.8.Italy market size and forecast, by application
6.3.4.10.Rest of Europe market size and forecast, by device type
6.3.4.11.Rest of Europe market size and forecast, by application

6.4.Asia-Pacific

6.4.1.Key market trends and opportunities
6.4.2.Market size and forecast, by device type
6.4.3.Market size and forecast, by application
6.4.4.Market size and forecast, by country

6.4.4.1.Japan market size and forecast, by device type
6.4.4.2.Japan market size and forecast, by application
6.4.4.3.China market size and forecast, by device type
6.4.4.4.China market size and forecast, by application
6.4.4.5.India market size and forecast, by device type
6.4.4.6.India market size and forecast, by application
6.4.4.7.Australia market size and forecast, by device type
6.4.4.8.Australia market size and forecast, by application
6.4.4.9.Rest of Asia-Pacific market size and forecast, by device type
6.4.4.10.Rest of Asia-Pacific market size and forecast, by application

6.5.LAMEA

6.5.1.Key market trends and opportunities
6.5.2.Market size and forecast, by device type
6.5.3.Market size and forecast, by application
6.5.4.Market size and forecast, by country

6.5.4.1.Brazil market size and forecast, by device type
6.5.4.2.Brazil market size and forecast, by application
6.5.4.3.Saudi market size and forecast, by device type
6.5.4.4.Saudi market size and forecast, by application
6.5.4.5.South Africa market size and forecast, by device type
6.5.4.6.South Africa market size and forecast, by application
6.5.4.7.Rest of LAMEA market size and forecast, by device type
6.5.4.8.Rest of LAMEA market size and forecast, by application

CHAPTER 7:COMPANY PROFILES

7.1.Abbott Laboratories

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments

7.2.Aleva Neurotherapeutics SA

7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Key strategic moves and developments

7.3.Boston Scientific Corporation

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments

7.4.ElectroCore Inc.

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance

7.5.EndoStim Inc.

7.5.1.Company overview
7.5.2.Operating business segments
7.5.3.Product portfolio

7.6.Medtronic plc

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
Source: Corporate Publications and AMR Analysis

7.7.NeuroPace Inc.

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Key strategic moves and developments

7.8.Nevro Corporation

7.8.1.Company overview
7.8.2.Operating business segment
7.8.3.Product portfolio
7.8.4.Business performances
7.8.5.Key strategic moves and developments

7.9.Neuronetics Inc.

7.9.1.Company overview
7.9.2.Neuronetics: Company Snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.9.6.Key strategic moves and developments

7.10.NeuroSigma Inc.

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Key strategic moves and developments

7.11.Synapse Biomedical Inc.

7.11.1.Company overview
7.11.2.Company snapshot
7.11.3.Operating business segments
7.11.4.Product portfolio
7.11.5.Key strategic moves and developments